Diorasis Therapeutics
PrivateLast Round
Series A
Nov 30, 2023
Company Overview
Diorasis Therapeutics is a biotechnology company developing disease-modifying, gene-agnostic therapies for glaucoma and other ophthalmic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Diorasis Therapeutics Comparables
Compare Diorasis Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eyegenex Inc. | 83% | |
| SparingVision | 78% | |
| Nanoscope Therapeutics Inc. | 78% |
Diorasis Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 30, 2023 | ||||
| Seed | Nov 1, 2023 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 30, 2023
$23M round completed.
- Nov 1, 2023
Completed a Seed funding round.
Diorasis Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Diorasis Therapeutics's valuation, stock price, and market status.
Is Diorasis Therapeutics a public or private company?
Diorasis Therapeutics is a private company.
What is the current stock price of Diorasis Therapeutics?
Diorasis Therapeutics is a private company with no public stock price. Caplight tracks Diorasis Therapeutics's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Diorasis Therapeutics worth (valuation)?
Valuation information for Diorasis Therapeutics is not publicly available.
Can I buy Diorasis Therapeutics stock?
Diorasis Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Diorasis Therapeutics's last funding round?
Diorasis Therapeutics's most recent funding round was Series A on November 30, 2023.
Who are the main investors in Diorasis Therapeutics?
Investor information for Diorasis Therapeutics is not publicly disclosed.
Will Diorasis Therapeutics IPO soon?
No public IPO plans have been announced for Diorasis Therapeutics.
How can I track Diorasis Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Diorasis Therapeutics's secondary market activity and sign up for updates.